Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis
Background: No consensus has been reached regarding the optimal therapy for visceral leishmaniasis (VL), which affects ~12 million people worldwide.Case Presentation: This report described four cases of VL encountered in the First Affiliated Hospital of Xi'an Jiaotong University between October...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/70ab15800e874ed78577a2321e14521b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|